Literature DB >> 7676709

Long-term outcome of cholecystoenterostomy as a definitive biliary drainage procedure for benign disease.

A J Oishi1, M G Sarr, D M Nagorney, M D Traynor, P Mucha.   

Abstract

Our aim was to examine the long-term success of cholecystoenterostomy performed for the relief of benign extrahepatic biliary obstruction. Concern about the ability of cholecystoenterostomy to provide reliable long-term biliary decompression has led many to abandon its use for benign biliary obstruction. Thirty-four patients who underwent cholecystoenterostomy for benign biliary obstruction over a 17-year period were reviewed. Patients were followed until cholecystoenterostomy failure, death, or to date. Failure was defined as recurrent biliary obstruction or cholangitis requiring therapeutic intervention. Mean follow-up was 8.0 years. Early postoperative morbidity occurred in 11 patients (32%), but only one early complication (cholangitis) was related directly to the cholecystoenteric anastomosis. Five patients (15%) experienced late biliary tract complications related directly to the cholecystoenterostomy including recurrent biliary stones with biliary obstruction in four and anastomotic stricture in one. All required reoperation and conversion to choledochoenterostomy at a mean of 112 months. Cholecystoenterostomy can provide reasonably effective long-term biliary decompression in selected patients with benign biliary obstruction.

Entities:  

Mesh:

Year:  1995        PMID: 7676709     DOI: 10.1007/bf00294736

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  BYPASS OPERATIONS FOR NEOPLASTIC BILIARY TRACT OBSTRUCTION.

Authors:  J A BUCKWALTER; R L LAWTON; R T TIDRICK
Journal:  Am J Surg       Date:  1965-01       Impact factor: 2.565

2.  Chronic pancreatitis: a cause of biliary stricture.

Authors:  W J Schulte; A J LaPorta; R E Condon; G F Unger; J E Geenen; J J DeCosse
Journal:  Surgery       Date:  1977-09       Impact factor: 3.982

3.  A comparison of choledochoenteric bypass and cholecystoenteric bypass in patients with biliary obstruction due to pancreatic cancer.

Authors:  A S Rosemurgy; C M Burnett; J A Wasselle
Journal:  Am Surg       Date:  1989-01       Impact factor: 0.688

4.  Recurrent cholangitis with and without anastomotic stricture after biliary-enteric bypass.

Authors:  J B Matthews; H U Baer; W P Schweizer; P Gertsch; T Carrel; L H Blumgart
Journal:  Arch Surg       Date:  1993-03

5.  Common duct stricture from chronic pancreatitis.

Authors:  J Yadegar; R A Williams; E Passaro; S E Wilson
Journal:  Arch Surg       Date:  1980-05

6.  Sump syndrome following choledochoduodenostomy and its endoscopic treatment.

Authors:  A R Baker; J P Neoptolemos; D L Carr-Locke; D P Fossard
Journal:  Br J Surg       Date:  1985-06       Impact factor: 6.939

7.  Surgical treatment of biliary complications from calcifying chronic pancreatitis.

Authors:  J E da Cunha; T Bacchella; C B Mott; J Jukemura; E E Abdo; M C Machado
Journal:  Int Surg       Date:  1984 Apr-Jun

8.  Surgical management of unresectable carcinoma of the pancreas.

Authors:  M G Sarr; J L Cameron
Journal:  Surgery       Date:  1982-02       Impact factor: 3.982

9.  A comparison of cholecysto- and choledochoenterostomy for obstructing pancreatic cancer.

Authors:  M D Rappaport; M Villalba
Journal:  Am Surg       Date:  1990-07       Impact factor: 0.688

10.  Efficacy of the gallbladder for drainage in biliary obstruction: a comparison of malignant and benign disease.

Authors:  M T Dayton; L W Traverso; W P Longmire
Journal:  Arch Surg       Date:  1980-09
View more
  2 in total

1.  Gallbladder carcinoma as a long-term complication of cholecystojejunostomy.

Authors:  Charles H C Pilgrim; Laveniya Satgunaseelan; Salena M Ward; Peter M Evans
Journal:  J Gastrointest Surg       Date:  2009-04-16       Impact factor: 3.452

Review 2.  Management of biliary and duodenal complications of chronic pancreatitis.

Authors:  Joseph D Vijungco; Richard A Prinz
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.